202 related articles for article (PubMed ID: 28125507)
1. Behavioural effects of novel multitarget anticholinesterasic derivatives in Alzheimer's disease.
Giménez-Llort L; Ratia M; Pérez B; Camps P; Muñoz-Torrero D; Badia A; Clos MV
Behav Pharmacol; 2017 Apr; 28(2 and 3-Spec Issue):124-131. PubMed ID: 28125507
[TBL] [Abstract][Full Text] [Related]
2. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A
Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242
[TBL] [Abstract][Full Text] [Related]
3. Donepezil: an important prototype to the design of new drug candidates for Alzheimer's disease.
Rodrigues Simões MC; Dias Viegas FP; Moreira MS; de Freitas Silva M; Riquiel MM; da Rosa PM; Castelli MR; dos Santos MH; Soares MG; Viegas C
Mini Rev Med Chem; 2014 Jan; 14(1):2-19. PubMed ID: 24251806
[TBL] [Abstract][Full Text] [Related]
4. Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease.
Camps P; Cusack B; Mallender WD; El Achab RE; Morral J; Muñoz-Torrero D; Rosenberry TL
Mol Pharmacol; 2000 Feb; 57(2):409-17. PubMed ID: 10648652
[TBL] [Abstract][Full Text] [Related]
5. AVCRI104P3, a novel multitarget compound with cognition-enhancing and anxiolytic activities: studies in cognitively poor middle-aged mice.
Giménez-Llort L; Ratia M; Pérez B; Camps P; Muñoz-Torrero D; Badia A; Clos MV
Behav Brain Res; 2015 Jun; 286():97-103. PubMed ID: 25732954
[TBL] [Abstract][Full Text] [Related]
6. Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases.
Galdeano C; Viayna E; Sola I; Formosa X; Camps P; Badia A; Clos MV; Relat J; Ratia M; Bartolini M; Mancini F; Andrisano V; Salmona M; Minguillón C; González-Muñoz GC; Rodríguez-Franco MI; Bidon-Chanal A; Luque FJ; Muñoz-Torrero D
J Med Chem; 2012 Jan; 55(2):661-9. PubMed ID: 22185619
[TBL] [Abstract][Full Text] [Related]
7. Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies.
Sola I; Aso E; Frattini D; López-González I; Espargaró A; Sabaté R; Di Pietro O; Luque FJ; Clos MV; Ferrer I; Muñoz-Torrero D
J Med Chem; 2015 Aug; 58(15):6018-32. PubMed ID: 26181606
[TBL] [Abstract][Full Text] [Related]
8. Tacrine derivatives and Alzheimer's disease.
Tumiatti V; Minarini A; Bolognesi ML; Milelli A; Rosini M; Melchiorre C
Curr Med Chem; 2010; 17(17):1825-38. PubMed ID: 20345341
[TBL] [Abstract][Full Text] [Related]
9. Novel tacrine analogs as potential cholinesterase inhibitors in Alzheimer's disease.
El-Malah A; Gedawy EM; Kassab AE; Salam RM
Arch Pharm (Weinheim); 2014 Feb; 347(2):96-103. PubMed ID: 24343873
[TBL] [Abstract][Full Text] [Related]
10. Potent Acetylcholinesterase Inhibitors: Potential Drugs for Alzheimer's Disease.
Akıncıoğlu H; Gülçin İ
Mini Rev Med Chem; 2020; 20(8):703-715. PubMed ID: 31902355
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015).
McHardy SF; Wang HL; McCowen SV; Valdez MC
Expert Opin Ther Pat; 2017 Apr; 27(4):455-476. PubMed ID: 27967267
[TBL] [Abstract][Full Text] [Related]
12. Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.
Jameel E; Meena P; Maqbool M; Kumar J; Ahmed W; Mumtazuddin S; Tiwari M; Hoda N; Jayaram B
Eur J Med Chem; 2017 Aug; 136():36-51. PubMed ID: 28478343
[TBL] [Abstract][Full Text] [Related]
13. Huprine X and huperzine A improve cognition and regulate some neurochemical processes related with Alzheimer's disease in triple transgenic mice (3xTg-AD).
Ratia M; Giménez-Llort L; Camps P; Muñoz-Torrero D; Pérez B; Clos MV; Badia A
Neurodegener Dis; 2013; 11(3):129-40. PubMed ID: 22626981
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and multitarget biological profiling of second-generation anti-Alzheimer rhein-huprine hybrids.
Pérez-Areales FJ; Betari N; Viayna A; Pont C; Espargaró A; Bartolini M; De Simone A; Rinaldi Alvarenga JF; Pérez B; Sabate R; Lamuela-Raventós RM; Andrisano V; Luque FJ; Muñoz-Torrero D
Future Med Chem; 2017 Jun; 9(10):965-981. PubMed ID: 28632395
[TBL] [Abstract][Full Text] [Related]
15. Dual binding site acetylcholinesterase inhibitors: potential new disease-modifying agents for AD.
del Monte-Millán M; García-Palomero E; Valenzuela R; Usán P; de Austria C; Muñoz-Ruiz P; Rubio L; Dorronsoro I; Martínez A; Medina M
J Mol Neurosci; 2006; 30(1-2):85-8. PubMed ID: 17192640
[TBL] [Abstract][Full Text] [Related]
16. Bis(9)-(-)-nor-meptazinol as a novel dual-binding AChEI potently ameliorates scopolamine-induced cognitive deficits in mice.
Liu T; Xia Z; Zhang WW; Xu JR; Ge XX; Li J; Cui Y; Qiu ZB; Xu J; Xie Q; Wang H; Chen HZ
Pharmacol Biochem Behav; 2013 Mar; 104():138-43. PubMed ID: 23262302
[TBL] [Abstract][Full Text] [Related]
17. Novel bis-(-)-nor-meptazinol derivatives act as dual binding site AChE inhibitors with metal-complexing property.
Zheng W; Li J; Qiu Z; Xia Z; Li W; Yu L; Chen H; Chen J; Chen Y; Hu Z; Zhou W; Shao B; Cui Y; Xie Q; Chen H
Toxicol Appl Pharmacol; 2012 Oct; 264(1):65-72. PubMed ID: 22842334
[TBL] [Abstract][Full Text] [Related]
18. Novel huprine derivatives with inhibitory activity toward β-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates.
Viayna E; Gómez T; Galdeano C; Ramírez L; Ratia M; Badia A; Clos MV; Verdaguer E; Junyent F; Camins A; Pallàs M; Bartolini M; Mancini F; Andrisano V; Arce MP; Rodríguez-Franco MI; Bidon-Chanal A; Luque FJ; Camps P; Muñoz-Torrero D
ChemMedChem; 2010 Nov; 5(11):1855-70. PubMed ID: 20859987
[TBL] [Abstract][Full Text] [Related]
19. Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography.
Zha X; Lamba D; Zhang L; Lou Y; Xu C; Kang D; Chen L; Xu Y; Zhang L; De Simone A; Samez S; Pesaresi A; Stojan J; Lopez MG; Egea J; Andrisano V; Bartolini M
J Med Chem; 2016 Jan; 59(1):114-31. PubMed ID: 26632651
[TBL] [Abstract][Full Text] [Related]
20. Dimeric Tacrine(10)-hupyridone as a Multitarget-Directed Ligand To Treat Alzheimer's Disease.
Xuan Z; Gu X; Yan S; Xie Y; Zhou Y; Zhang H; Jin H; Hu S; Mak MSH; Zhou D; Keung Tsim KW; Carlier PR; Han Y; Cui W
ACS Chem Neurosci; 2021 Jul; 12(13):2462-2477. PubMed ID: 34156230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
